Clinical Trials Logo
  1. Home
  2. Chronic Inflammation
  3. NCT05209867

Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV

Chronic Inflammation Clinical Trial

Official title:
CBD-induced Biomarkers of Inflammation Reduction in People Living With HIV at the Single Cell Level

Clinical Trial Summary

People living with HIV (PLWH) are affected by comorbidities appearing to be strongly related to chronic inflammation, a condition characterizing PLWH. The investigators propose to study the effects of CBD on inflammation in PLWH, and establish the molecular role of different immune cells in this process. The investigators plan to use single cell RNA-sequencing (scRNAseq) to isolate CBD-specific cellular phenotypes from five persons with HIV who will provide blood samples before and after taking CBD.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05209867
Study type Interventional
Source University of Florida
Contact
Status Completed
Phase Phase 4
Start date May 1, 2022
Completion date December 12, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Recruiting NCT05068557 - EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) N/A
Not yet recruiting NCT05050812 - The Grounded Brain: How Sleeping Grounded Affects Memory and Perceptions N/A
Recruiting NCT02395354 - Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease N/A
Completed NCT01686204 - Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt N/A
Completed NCT02963662 - Impact of Gut Hormones and Inflammatory Adipokines in Obese Patients Underwent Bariatric Surgery N/A
Recruiting NCT05304689 - Analysis of the Relationship Between the Quantitative Index of Cytokines in the Oral Fluid and Inflammation N/A
Recruiting NCT06401785 - To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases Phase 2
Terminated NCT00211471 - Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.). Phase 2
Recruiting NCT04447144 - Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome
Not yet recruiting NCT06444763 - Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population Phase 3
Terminated NCT02661295 - A Study of Ferric Citrate to Improve Inflammation and Lipid Levels Phase 4
Completed NCT02506192 - Gulf War Illness Inflammation Reduction Trial Phase 2
Completed NCT04023318 - The BMI Project (Body, Mind, Inflammation) N/A
Recruiting NCT04971408 - Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury N/A
Enrolling by invitation NCT02520206 - Adenosylmethionine Metabolism in Human Inflammation N/A
Recruiting NCT05392582 - MicroRNA Regulation of Chronic Inflammation During Aging
Recruiting NCT04979130 - Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) Phase 4
Completed NCT04636723 - Neuroinflammation in Chronic Systemic Symptoms (CSS)
Completed NCT02084381 - PERCI- Medium Cut Off (MCO) N/A